Rate My Professor Roz Wilson

University of Otago

5.0

1 review · out of 5

Rate Roz

Is this you? Claim this profile

Ratings & reviews

5.04/23/2026

Inspires confidence and independent thinking.

Taught by or worked with Roz?

Add your rating. It takes about 30 seconds.

About Roz

Dr. Ross Wilson serves as a Senior Research Fellow in the Centre for Musculoskeletal Outcomes Research (CMOR) within the Department of Surgical Sciences at the Dunedin School of Medicine, University of Otago. He earned his PhD in Economics from Lund University, Sweden, in 2016, and a BCom with First Class Honours from the University of Otago between 2006 and 2010. Since 2018, Wilson has been affiliated with the University of Otago, contributing to health economics research focused on musculoskeletal disorders within the New Zealand healthcare system.

Wilson's academic interests center on health economics, including the valuation and measurement of health-related quality of life (HRQoL) for economic evaluations, cost-effectiveness analyses of healthcare interventions, and simulation modeling of disease progression and treatments to guide policy decisions. His work addresses key challenges such as the management of osteoarthritis, multimorbidity in primary care, and gout prophylaxis. Notable impacts include projections that knee osteoarthritis costs in New Zealand could nearly double to $370 million and research indicating that New Zealand's average body mass index will exceed the obesity threshold by the early 2030s if current trends persist. Key publications encompass Pryymachenko, Y., Wilson, R., Dalbeth, N., Abbott, J. H., & Stamp, L. (2025). Cost-effectiveness of low dose colchicine prophylaxis when starting allopurinol using the “start-low go-slow” approach for gout: Evidence from a non-inferiority randomised double-blind placebo-controlled trial. Arthritis Care & Research; Lim, Y. W., Al-Busaidi, I. S., Caya, R., Bricca, A., Mangin, D., Wilson, R., & Abbott, J. H. (2025). Effectiveness of interventions for the management of multimorbidity in primary care and community settings: Systematic review and meta-analysis. Family Practice; Pierobon, A., Gaspar Fernandes, L., Wilson, R., Christopherson, R. M., Stanley, J., Pryymachenko, Y., Lim, Y. W., Caya, R., Gayed, M., & Abbott, J. H. (2025). Validity of the Global Rating of Change in patients with chronic low back pain. Musculoskeletal Science & Practice; Wilson, R. et al. (2018). Development and validation of a new population-based simulation model of osteoarthritis in New Zealand; Abbott, J. H. et al. (2020). The cost-effectiveness of recommended adjunctive interventions for knee osteoarthritis: Results from a computer simulation model; Wilson, R. et al. (2019). Long-term cost-effectiveness of exercise therapy and/or manual therapy for hip or knee osteoarthritis: Randomized controlled trial and computer simulation modelling; Wilson, R. & Abbott, J. H. (2018). Age, period and cohort effects on body mass index in New Zealand, 1997-2038. Australian & New Zealand Journal of Public Health. His publications have accumulated over 940 citations.